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1. Introduction 
Glucuronidation has been shown to be a common 
detoxication mechanism for a variety of foreign and 
endogenous compounds [I]. However, except for the 
enzyme(s) catalyzing the glucuronidation of bilirubin 
[2], 1-naphtol and morphine [3], knowledge about 
the characteristics of UDP-glucuronyltransferase(s) 
in man is scanty. Since bile acid glucuronides were 
detected about 6 years ago [4,5], bile acid glu- 
curonidation seems also to be a detoxication 
mechanism in addition to the well-known bile acid 
sulphation (review [6]). However, nothing is known 
about the bile acid UDP-glucuronyltransferase in 
man. Only some properties of this enzyme from rat 
liver have been reported [7]. In this paper catalytic 
properties, the effect of detergents on enzyme 
activity and studies on aglycone substrate specificity 
of the bile acid UDP-glucuronyltransferase from 
human liver are described. The enzyme was com- 
petitively inhibited by bilirubin and estradiol, non- 
competitively by testosterone and uncompetitively 
by 4-nitrophenol, whereas morphine had no effect 
on bile acid UDP-glucuronyltransferase activity, 
suggesting that in human liver bile acids, bilirubin 
and estradiol may be glucuronidated by the same 
enzyme. 
2. Materials and methods 
Specimens of human liver were obtained for 
histological examination from surgical patients who 
had undergone laparotomy for cholecystectomy 
because of cholelithiasis. Only laparotomy specimens 
with normal hepatic histology were used. The liver 
Elsevier/North-Holland Biomedical Press 
tissue was immediately frozen at -20°C. The activity 
of bile acid UDP-glucuronyltransferase was found to 
be stable for at least 4 weeks under these conditions. 
A 10% homogenate (wet wt/vol.) was prepared with 
0.25 M sucrose in 5 mM Tris-HCl (pH 7.4) using a 
glass homogenizer with a teflon pestle. 
For the determination of bile acid UDP-glucuronyl- 
transferase activity, human liver homogenate cor- 
responding to -2 mg liver (wet wt) was incubated for 
30 min at 37°C in a reaction mixture containing 
0.5 mM [14C]chenodeoxycholic acid (0.8 &i/pmol), 
9 mM UDP-glucuronic acid, 5 mM MgCl?, 5 mM 
saccharolactone and 0.1 M imidazole-HCl (pH 6.8). 
Details of the assay and product identification are 
in [8]. Bilirubin UDP-glucuronyltransferase was 
determined as in [2] with the following modifica- 
tions: the final concentrations of bilirubin and of 
UDP-glucuronic acid were 0.17 mM and 9 mM, 
respectively; the reaction mixture contained 0.1 M 
imidazole-HCl (pH 6.7) as buffer. 
UDP-glucuronic acid was obtained from Boeh- 
ringer (Mannheim); [24-14C] chenodeoxycholic acid 
from NEN Chemicals (Dreieich); saccharolactone 
from Sigma (Miinchen) and bile acids from Steraloids 
(Wilton, USA). All other chemicals were from Merck 
(Darmstadt). 
3. Results and discussion 
3.1. Effect of detergents 
Since UDP-glucuronyltransferases are pre- 
dominantly microsomal enzymes [l] surface-active 
agents activate these membrane-bound enzymes by 
altering the membrane structure [lo]. Therefore, the 
effect of detergents on the activity of bile acid UDP- 
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glucuronyltransferase from human liver homogenate 
has been investigated. The enzyme was activated 1.6- 
fold by 0.01% (v/v) Triton X-100 and 1.8-fold by 
digitonin (0.6 mglmg liver protein) when a non- 
saturating substrate concentration (0.0 1 mM chenode- 
oxycholic acid) was used. Higher concentrations of 
Triton X-100 or digitonin inhibited the enzyme. At 
saturating substrate concentration (0.5 mM 
chenodeoxycholic acid) Triton X-100 and digitonin 
had no activating effect on enzyme activity indicating 
that the enzyme is fully activated in the presence of 
0.5 mM chenodeoxycholic acid due to the surface- 
active effect of the bile acid. Therefore, the enzyme 
has only been assayed in the fully activated state 
which was achieved either by 0.5 mM chenodeoxy- 
cholic acid as substrate or by the presence of 
0.01% Triton X-100 at <0.5 mM chenodeoxycholic 
acid. 
3.2. Gz taly tic properties 
Lineweaver-Burk plots of the initial rates of 
enzyme activity as a function of varying concentra- 
tions of chenodeoxycholic acid in the presence of 
0.01% Triton X-100 yielded a straight line from 
which the app. Km was calculated to be 0.083 mM 
chenodeoxycholic acid. The V,, was 2.4 nmol. 
h-’ . mg protein-’ . When UDP-glucuronic acid was 
used as the variable substrate and chenodeoxycholic 
acid was kept constant at 0.5 mM, the app. K, 
Table 1 
Effect of divalent metal ions on bile acid UDP-glucuro- 
nyltransferase activity 
Addition 
to assay 
Bile acrd UDP-glucuronyl- 
transferase activity 
(%I control)a 
None 
10 mM FDTA 
5 mM Mg2+ 
5 mM Mn’+ 
5 mM Cazt 
5 mM Co*’ 
5 mM NI*+ 
5 mM Zn2* 
5 mM Fe*+ 
-___ 
100 
97 
138 
134 
135 
35 
44 
6 
13 
a Control: lnzyme activity without addition of EDTA and 
metal ions 
For the determination of enzyme activity, see section 2 
for UDP-glucuronic acid was determined to be 
0.96 mM (not shown). 
The effect of divalent metal ions on the activity of 
bile acid UDP-glucuronyltransferase is shown in 
table 1. The enzyme was stimulated to -140% by 
5 mM Mg*’ in comparison to the control value. No 
further increase or decrease in enzyme activity was 
observed when Mg” was 4- 15 mM (not shown). 
The glucuronidation of bilirubin in human liver was 
also stimulated by the addition of Mg*+ [2]. Mn*+ 
Table 2 
Effect of bile acids on the glucuronidation of chenodeoxycholic acid 
Bile acid Bile acid 
(mM) 
Lithocholic acid (301-01) 0.1 
0.5 
Chenodeoxycholic acid (301,7or-01) 0.1 
0.5 
Ursodeoxycholic acid (301,7p-01) 0.1 
0.5 
Deoxycholic acid (3a,12or-01) 01 
0.5 
Chohc acid (3q701,12or-01) 0.1 
0.5 
% Inhibition of chenodeoxycholic acid glucuronidation 
in the presence of 
Unconjugated Clycine conjugated Taurine conjugated 
bile acid bile actd bile acid 
62 51 58 
91 98 
28 33 
_ 76 90 
27 17 
69 25 _ 
42 45 51 
99 91 99 
16 15 19 
21 24 44 
Enzyme activity was assayed in the presence of 0.5 mM chenodeoxycholic acid as in sectron 2. Lithocholic acid 
(unconjugated or conjugated with glycme or taurine) was dissolved in ethylene glycol containing 1% (v/v) 
ethanolamine (final cont. solvent 19.2%’ (v/v)). The position and configuration of the hydroxyl groups in the 
bile acid skeleton is given in brackets 
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and Ca2+ could replace Mg” in the stimulation of bile 
acid UDP-glucuronyltransferase, whereas Co’+, 
Ni2+, Zn2+ or Fe” inhibited the enzyme (table 1). 
03 mM 
The influence of the pH upon the activity of bile 
acid UDP-glucuronyltransferase was investigated at 
pH 6.0-8.0 in 0.1 M potassium phosphate buffer. 
The enzyme activity was optimal at pH 6.7 and 
declined steeply towards pH 6.0 and 8.0. 
3.3. Studies on aglycone substrate specificity 
The affinity of the enzyme to different bile acids 
has been investigated by studying the influence of 
various bile acids on the enzymatic glucuronidation 
of chenodeoxycholic acid (table 2). The affinity of 
the unconjugated bile acids to the enzyme decreased 
with increasing number of hydroxyl groups in the 
bile acid skeleton. The glucuronidation of cheno- 
deoxycholic acid was inhibited in the presence of 
0.1 mM lithocholic acid, a monohydroxylated bile 
acid, by 62%, whereas only 16% inhibition of cheno- 
deoxycholic acid glucuronidation was observed by 
0.1 mM cholic acid, a trihydroxylated bile acid. 
The degree of inhibition of chenodeoxycholic acid 
glucuronidation observed in the presence of 
dihydroxylated bile acids shows, that the affinity of 
the bile acids to the enzyme seems to depend not 
only on the number but also on the position and 
configuration of hydroxyl groups in the bile acid 
skeleton. Compared to the corresponding uncon- 
jugated bile acids, the affinity of the glycine conjugat- 
CDCA 
- 0.24 -0.08 0.68 0.2JG 
Estradiol(mM) 
015mM 
1.0 
0.8 
0.6 
0.3mM 
I 
I I I I I t I 
-0.3 -0.1 0.1 0.2 0.3 0.4 
Bilirubin (mM) 
i 1 i I 
Testosterone (mM) 
Fig.1. Inhibition of bile acid UDP-glucuronyltransferase 
by bilirubin (A), estradiol-170 (B) and testosterone (C) 
(Dixon plots). The concentrations of chenodeoxycholic acid 
(CDCA) used are shown in the figure. Bilirubin, estradiol and 
testosterone were dissolved as described in the legend to 
table 2. For the determination of enzyme activity, see sec- 
tion 2. Triton X-100 was added to the reaction mixtures in 
final cont. 0.01% (v/v). Y = nmol. h-l. mg protein-‘. 
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ed bile acids to the enzyme was similar or lower, 
whereas the taurine conjugated bile acids showed a 
similar or higher affinity to the enzyme (table 2). 
In human liver evidence exists that there is more 
than one UDP-glucuronyltransferase. In human liver 
1 naphtol, morphine and bilirubin may be glu- 
curonidated by separate forms of enzymes [3]. In rat 
liver the existence of at least two different UDP- 
glucuronyltransferases could be shown by isolation of 
two enzymes which differed in the substrate speci- 
ficity towards planar compounds like 4nitrophenol 
and substrates containing non-planar portions like 
morphine [ 111. Whether or not the recently purified 
bilirubin UDP-glucuronyltransferase from rat liver 
[ 121 is identical with the enzyme specific for non-pla- 
nar substrates isolated in [ 1 l] remains to be 
established. 
In order to obtain evidence for the aglycone sub- 
strate specificity of the bile acid UDP-glucuronyl- 
transferase from human liver the influence of the 
following foreign and endogenous substrates on the 
glucuronidation of chenodeoxycholic acid was 
investigated: 4nitrophenol and morphine as foreign 
substrates, and bilirubin, estradiol as well as 
testosterone as endogenous substrates. Whereas 
15 mM morphine had no effect on the glucuronida- 
tion of chenodeoxycholic acid, the activity of bile 
acid UDP-glycuronyltransferase was inhibited by 
-60% in the presence of 5 mM 4nitrophenol or 
4 mM testosterone and by -40% in the presence of 
0.25 mM bilirubin or 0.25 mM estradiol. Inhibition 
kinetics were performed with these substrates 
according to Dixon (fig.1) and to Lineweaver-Burk 
(not shown). Bilirubin (fig.lA) and estradiol (fig.lB) 
competitively inhibited the glucuronidation of cheno- 
deoxycholic acid with app. Ki 0.28 mM for bilirubin 
and 0.26 mM for estradiol. Testosterone exhibited a 
noncompetitive inhibition pattern with an app. Ki 
of 2.2 mM testosterone (fig.lC) and 4nitrophenol 
showed an uncompetitive inhibition type (not 
shown). Furthermore, it could be shown, that the 
glucuronidation of chenodeoxycholic acid was not 
only inhibited by bilirubin, but that conversely, the 
glucuronidation of bilirubin was inhibited by 40% 
in the presence of 1 mM chenodeoxycholic acid at 
pH 6.7. These studies suggest hat in human liver 
bile acids, bilirubin and estradiol may be glu- 
curonidated by the same enzyme, whereas morphine, 
4nitrophenol and testosterone may be substrates 
for a separate or different form(s) of UDP-glucuronyl- 
transferase(s). However, definite proof can only be 
obtained from specificity studies with the purified 
UDP-glucuronyltransferase. Since an enzyme purifica- 
tion can only be performed when large amounts of 
starting material are available, purification of the 
bile acid UDP-glucuronyltransferase from rat liver 
is now in progress. 
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